日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The contribution of neutrophils to bacteriophage clearance and pharmacokinetics in vivo

中性粒细胞对噬菌体清除和体内药代动力学的贡献

Echterhof, Arne; Dharmaraj, Tejas; Khosravi, Arya; McBride, Robert; Miesel, Lynn; Chia, Ju-Hsin; Blankenberg, Patrick M; Lin, Kun-Yuan; Shen, Chien-Chang; Lee, Yu-Ling; Yeh, Yu-Chuan; Liao, Wei Ting; Blankenberg, Francis G; Dąbrowska, Krystyna; Amanatullah, Derek F; Frymoyer, Adam R; Bollyky, Paul L

Efficacy of Rezafungin in Prophylactic Mouse Models of Invasive Candidiasis, Aspergillosis, and Pneumocystis Pneumonia

瑞扎芬净在侵袭性念珠菌病、曲霉病和卡氏肺囊虫肺炎预防小鼠模型中的疗效

Miesel, Lynn; Cushion, Melanie T; Ashbaugh, Alan; Lopez, Santiago R; Ong, Voon

FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development

FDA公开研讨会摘要:推进抗菌药物研发的动物模型

Byrne, James M; Waack, Ursula; Weinstein, Edward A; Joshi, Abhay; Shurland, Simone M; Iarikov, Dmitri; Bulitta, Jürgen B; Diep, Binh An; Guina, Tina; Hope, William W; Lawrenz, Matthew B; Lepak, Alexander J; Luna, Brian M; Miesel, Lynn; Phipps, Andrew J; Walsh, Thomas J; Weiss, William; Amini, Thushi; Farley, John J

Potent LpxC Inhibitors with In Vitro Activity against Multidrug-Resistant Pseudomonas aeruginosa

具有体外抗多重耐药铜绿假单胞菌活性的强效LpxC抑制剂

Krause, Kevin M; Haglund, Cat M; Hebner, Christy; Serio, Alisa W; Lee, Grace; Nieto, Vincent; Cohen, Frederick; Kane, Timothy R; Machajewski, Timothy D; Hildebrandt, Darrin; Pillar, Chris; Thwaites, Mary; Hall, Danielle; Miesel, Lynn; Hackel, Meredith; Burek, Amanda; Andrews, Logan D; Armstrong, Eliana; Swem, Lee; Jubb, Adrian; Cirz, Ryan T

Rezafungin treatment in mouse models of invasive candidiasis and aspergillosis: Insights on the PK/PD pharmacometrics of rezafungin efficacy

在侵袭性念珠菌病和曲霉病小鼠模型中应用瑞扎芬净治疗:瑞扎芬净药代动力学/药效学疗效研究进展

Miesel, Lynn; Lin, Kun-Yuan; Ong, Voon

Pharmacological Basis of CD101 Efficacy: Exposure Shape Matters

CD101 疗效的药理学基础:暴露模式至关重要

Lakota, Elizabeth A; Bader, Justin C; Ong, Voon; Bartizal, Ken; Miesel, Lynn; Andes, David R; Bhavnani, Sujata M; Rubino, Christopher M; Ambrose, Paul G; Lepak, Alexander J

Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis.

Ramizol 是一种新型抗生素,用于治疗艰难梭菌结肠炎,目前正处于临床前开发阶段

Rao Shasha, Prestidge Clive A, Miesel Lynn, Sweeney Deb, Shinabarger Dean L, Boulos Ramiz A

Kibdelomycin is a potent and selective agent against toxigenic Clostridium difficile

基布德洛霉素是一种强效且选择性的抗产毒性艰难梭菌药物。

Miesel, Lynn; Hecht, David W; Osmolski, James R; Gerding, Dale; Flattery, Amy; Li, Fangbiao; Lan, Jing; Lipari, Philip; Polishook, Jon D; Liang, Lianzhu; Liu, Jenny; Olsen, David B; Singh, Sheo B